KIRs and their HLA ligands in remitting-relapsing multiple sclerosis

J Neuroimmunol. 2010 Dec 15;229(1-2):232-7. doi: 10.1016/j.jneuroim.2010.08.004. Epub 2010 Sep 9.

Abstract

Killer Immunoglobulin-like Receptor (KIR) genes may affect both resistance and susceptibility to autoimmune disorders, but their role in the pathogenesis of Multiple Sclerosis (MS) is still unclear. To evaluate the involvement of KIRs and their HLA ligands in the development of MS we performed genotyping of HLA -A, -B, -Cw, -DRB1 and KIRs loci in 121 RRMS patients and 103 healthy controls (HC). Results evidenced a possible protective role of the activating KIR2DS1 gene (p(y)=0.001; OR:0.38), enhanced in the presence of its ligand group HLA-C2 (p(y)=0.0001; OR:0.23). Our data suggest that the presence of functional compounds of activating KIR receptors together with their HLA ligands, allowing the immunomodulatory function of NK cells, may have a protective role against the disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Genotype
  • HLA Antigens / classification
  • HLA Antigens / genetics*
  • HLA Antigens / metabolism*
  • Humans
  • Ligands
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / genetics*
  • Multiple Sclerosis, Relapsing-Remitting / immunology
  • Multiple Sclerosis, Relapsing-Remitting / metabolism*
  • Odds Ratio
  • Receptors, KIR / genetics
  • Receptors, KIR / metabolism*
  • Young Adult

Substances

  • HLA Antigens
  • KIR2DS1 protein, human
  • Ligands
  • Receptors, KIR